Multicentre randomised controlled trial of the clinical and cost-effectiveness of a bypass-surgery-first versus a balloon-angioplasty-first revascularisation strategy for severe limb ischaemia due to infrainguinal disease. The Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial
Bradbury AW, Adam DJ, Bell J, Forbes JF, Fowkes FGR, Gillespie I, Raab G, Ruckley CV
Record ID 32001000750
English
Authors' recommendations:
Study found that patients with severe limb ischaemia who are expected to live for less than 2 years benefit from balloon angioplasty first, especially where there is no vein for bypass, whereas patients expected to survive for more than 2 years benefit from bypass surgery first, especially where a vein is available for bypass
Details
Project Status:
Completed
URL for project:
http://www.hta.ac.uk/1070
Year Published:
2010
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
England, United Kingdom
MeSH Terms
- Angioplasty, Balloon
- Ischemia
Contact
Organisation Name:
NIHR Health Technology Assessment programme
Contact Address:
NIHR Journals Library, National Institute for Health and Care Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton SO16 7NS, UK
Contact Name:
journals.library@nihr.ac.uk
Contact Email:
journals.library@nihr.ac.uk
Copyright:
2009 Queen's Printer and Controller of HMSO
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.